Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial

By sjmartinez • February 21, 2024

Schou M, Claggett B, Miao ZM, Fernandez A, Filippatos G, Granger C, Jering K, Maggioni AP, McCausland F, Villota JN, Rouleau JL, Mody FV, van der Meer P, Vinereanu D, McGrath M, Zhou Y, Mann DL, Solomon SD, Steg PG, Braunwald E, McMurray JJV, Pfeffer MA, Køber L. Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial. Eur J Heart Fail. 2024 Jan;26(1):130-139. doi: 10.1002/ejhf.3079. Epub 2023 Nov 29. PMID: 37933184.

Tags: ACE inhibitors, Cardiology/Epi, drug adherence, heart failure, left ventricular dysfunction, mineralocorticoid receptor antagonists, Myorcardial infarction, Publications, sacubitril/valsartan, Veterans Administration

Refractive Index-Corrected Light-Sheet Microscopy for Macro-View Cardiovascular Imaging

Zhu E, Zhang Y, Zhao P, Cho JM, Wang Z, Li YR, Wang J, Margolis S, Wang S, Yang L, Chu A, Zhang Y, Gao[...]

Bisphosphonate Use and Cardiovascular Outcomes According to Kidney Function Status in Post-Menopausal Women: An Emulated Target Trial from the Multi-Ethnic Study of Atherosclerosis

Ghotbi E, Subhas N, Bancks MP, Elmariah S, Halperin JL, Bluemke DA, Kestenbaum BR, Barr RG, Post WS, Budoff M, Lima JAC, Demehri S. Bisphosphonate[...]

Acute Cardiogenic Shock Secondary to Left Main Occlusion in a Patient with Behçet Disease

Sekhon HK, Sareh S, Kellner D, Yiu G, Benharash P, Hollowed J, Shahandeh N. Acute Cardiogenic Shock Secondary to Left Main Occlusion in a Patient[...]